Stephen E Gitelman

Stephen E Gitelman

UNVERIFIED PROFILE

Are you Stephen E Gitelman?   Register this Author

Register author
Stephen E Gitelman

Stephen E Gitelman

Publications by authors named "Stephen E Gitelman"

Are you Stephen E Gitelman?   Register this Author

52Publications

1311Reads

50Profile Views

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

N Engl J Med 2019 08 9;381(7):603-613. Epub 2019 Jun 9.

From the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.); the Departments of Epidemiology and Pediatrics, University of South Florida, Tampa (B.N.B., J.P.K., H.R.), the Department of Medicine, University of Miami, Miami (J.B.M., J.S.S.), and the Department of Pediatrics, University of Florida, Gainesville (D.S.) - all in Florida; Benaroya Research Institute, Seattle (S.A.L., M.J.D., P.S.L., C.J.G.); the Diabetes Center, University of California at San Francisco, San Francisco (J.A.B., S.E.G.); the Department of Pediatrics, Indiana University, Indianapolis (L.A.D.); the Barbara Davis Diabetes Center, University of Colorado, Anschultz (P.A.G.); Children's Mercy Hospital, Kansas City, MO (W.M.); the Department of Pediatrics, University of Minnesota, Minneapolis (A.M.); the Department of Pediatrics and Cell and Developmental Biology, Vanderbilt University, Nashville (W.E.R.); the Department of Pediatrics, University of Iowa, Iowa City (E.T.); the Hospital for Sick Children, University of Toronto, Toronto (D.K.W.); and Forschergruppe Diabetes, Technical University Munich, at Klinikum rechts der Isar, Munich, Germany (A.-G.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902226DOI Listing
August 2019

Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables.

Diabetologia 2019 01 30;62(1):33-40. Epub 2018 Aug 30.

The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-018-4722-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518395PMC
January 2019

Type 1 Diabetes and Celiac Disease: Causal Association or True, True, Unrelated?

Pediatrics 2017 11 10;140(5). Epub 2017 Oct 10.

Division of Endocrinology, Department of Pediatrics, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2017-2424DOI Listing
November 2017

Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs.

Transplantation 2017 10;101(10):2501-2507

1 Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France. 2 Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France. 3 Société d'Accélération du Transfert de Technologies Ouest Valorisation, Rennes, France. 4 Xenothera, Nantes, France. 5 Biomarker Discovery Research, Immune Tolerance Network, Bethesda, MD, USA. 6 IECM, Immuno-endocrinology, EA4644 Oniris, University of Nantes, USC1383 INRA, Oniris, Nantes, France. 7 Clinical Trials Group, Immune Tolerance Network, San Francisco, CA. 8 Division of Pediatric Endocrinology and Diabetes, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000001686DOI Listing
October 2017

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes.

Diabetes Care 2016 Dec;39(12):2218-2224

Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-0857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127223PMC
December 2016

Regulatory T cell therapy for type 1 diabetes: May the force be with you.

J Autoimmun 2016 07 28;71:78-87. Epub 2016 Apr 28.

Diabetes Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2016.03.011DOI Listing
July 2016

Recommendations for the definition of clinical responder in insulin preservation studies.

Diabetes 2014 Sep 10;63(9):3120-7. Epub 2014 Apr 10.

Department of Medicine, VA Puget Sound Health Care System, Seattle, WA University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://diabetes.diabetesjournals.org/cgi/doi/10.2337/db14-00
Publisher Site
http://dx.doi.org/10.2337/db14-0095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141373PMC
September 2014

Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials.

Pediatr Diabetes 2013 Aug 17;14(5):311-21. Epub 2013 Jun 17.

Department of Medicine and Diabetes Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pedi.12040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748836PMC
August 2013

Impact of an interactive online nursing educational module on insulin errors in hospitalized pediatric patients.

Diabetes Care 2010 Aug 26;33(8):1744-6. Epub 2010 May 26.

Department of Nursing, University of California, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc10-0031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909054PMC
August 2010

The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus.

Pediatr Diabetes 2008 Jun 22;9(3 Pt 2):69-73. Epub 2008 Jan 22.

Division of Endocrinology, Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143-0434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-5448.2007.00342.xDOI Listing
June 2008

Congenital hyperinsulinism in an infant caused by a macroscopic insulin-producing lesion.

J Pediatr Endocrinol Metab 2007 Mar;20(3):437-40

Department of Pediatrics, Division of Endocrinology, University of California, San Francisco 94143-0434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem.2007.20.3.437DOI Listing
March 2007

Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.

Pediatr Endocrinol Rev 2006 Dec;4 Suppl 1:66-70

University of California, San Francisco.

View Article

Download full-text PDF

Source
December 2006

Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.

Am J Med 2006 Jul;119(7 Suppl 1):S54-8

Department of Pediatrics, Division of Pediatric Endocrinology, University of California at San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2006.05.008DOI Listing
July 2006

Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.

J Pediatr 2006 Jan;148(1):128-31

Department of Pediatrics, Division of Endocrinology, University of California, San Francisco School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2005.08.031DOI Listing
January 2006

Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis.

J Pediatr Endocrinol Metab 2005 Sep;18(9):865-72

Pediatric Critical Care Medicine, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://www.degruyter.com/dg/viewarticle.fullcontentlink:pdfe
Web Search
http://dx.doi.org/10.1515/jpem.2005.18.9.865DOI Listing
September 2005

Nephrogenic syndrome of inappropriate antidiuresis.

N Engl J Med 2005 May;352(18):1884-90

Department of Pediatrics, Division of Endocrinology, University of California at San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa042743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340184PMC
May 2005

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.

Diabetes Care 2005 Jan;28(1):15-9

Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305-5208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.28.1.15DOI Listing
January 2005

The use of a continuous glucose monitoring system in hypoglycemic disorders.

J Pediatr Endocrinol Metab 2004 Mar;17(3):281-8

Department of Pediatrics, University of California at San Francisco, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem.2004.17.3.281DOI Listing
March 2004

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

N Engl J Med 2002 May;346(22):1692-8

Naomi Berrie Diabetes Center and the Department of Medicine, Division of Endocrinology, College of Physicians and Surgeons, Columbia University, New York 10032, USA.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMoa012864
Publisher Site
http://dx.doi.org/10.1056/NEJMoa012864DOI Listing
May 2002

Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus.

J Pediatr 2002 Feb;140(2):235-40

University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mpd.2002.120509DOI Listing
February 2002

Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis.

Pediatr Nephrol 2002 Jan;17(1):1-5

Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, CA 94143-0434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s004670200000DOI Listing
January 2002